Abstract
Purpose
The association of known ACE gene and eNOS gene polymorphisms with BD in a group of Turkish patients with or without ocular involvement has been investigated.
Methods
The ACE and eNOS gene polymorphisms were investigated in 73 BD patients and 90 controls.
Results
The distrubition of “DD”, “ID” and “II” genotypes of the ACE gene were 32 (43.8%), 29 (39.8%) and 12 (16.4%) for BD patients and 32 (35.5%), 35 (38.9%) and 23 (25.6%) for healthy controls. There was no significant difference between the groups (p = 0.140, OR 1.44, CI 0.90–2.30). When Behçet patients with ocular involvement were compared to the control group, statistical significance was found (p = 0.049, OR 2.18, CI 1.00–4.81). The “bb”, “ba”, and “aa” genotype frequencies of the eNOS gene were 48 (65.8%), 23 (31.5%), and 2 (2.7%) for patients with BD and 75 (83.3%), 15 (16.7%), and 0 (0%) for healthy controls, respectively. The significant difference found in allelic frequencies between the two groups (p = 0.011, OR 2.32, CI 1.11–4.87). When Behçet patients with ocular involvement were compared, sharper statistical significance was found (p = 0.001,OR 4.61,CI 1.85–11.52).
Discussion
The ACE gene polymorphism does not play a role in the pathogenesis of BD. The findings of the eNOS gene polymorphisms confirmed the significant association with BD and even more in patients with ocular involvement.
Similar content being viewed by others
References
Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;21:341(17):1284–91.
Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dundar SV, Kirazli S. Impaired haemostatic kinetics and endothelial function in Behcet’s disease. J Intern Med. 1996;240(4):181–7.
Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol. 2001;37(2):517–20.
Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373–80.
Savage CO, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun. 1993;6(2):237–49.
Farrell AJ, Blake DR. Nitric oxide. Ann Rheum Dis. 1996;55(1):7–20.
Hattori R, Sase K, Eizawa H, Kosuga K, Aoyama T, Inoue R, et al. Structure and function of nitric oxide synthases. Int J Cardiol. 1994;47(Suppl 1):S71–5.
Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res. 1999;15:43(3):521–31.
Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;15;268(23):17478–88.
Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoc M. Decreased nitric oxide production in patients with Behcet’s disease. Dermatology. 1999;198(1):33–6.
Osborne NN, Barnett NL, Herrera AJ. NADPH diaphorase localization and nitric oxide synthase activity in the retina and anterior uvea of the rabbit eye. Brain Res. 1993;610:194–8.
Henrion D, Benessiano J, Levy BI. In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery. Circ Res. 1997;80(2):189–95.
Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19(7):1623–9.
Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. Angiotensin-I converting enzyme gene is on chromosome 17. Cytogenet Cell Genet. 1989;51:1041.
Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;16:332(11):706–11.
Molad Y, Gal E, Magal N, Sulkes J, Mukamel M, Weinberger A, et al. Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism. Semin Arthritis Rheum. 2000;30(2):132–7.
International Study group for Behçet’s Disease-towards internationally agreed criteria. Br J Rheumatol. 1992;31:299–308.
Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension. 1990;16(4):363–70.
Rogerson FM, Chai SY, Schlawe I, Murray WK, Marley PD, Mendelsohn FA. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens. 1992;10(7):615–20.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–6.
Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 1996;27:465–75.
Sato H, Akai Y, Iwano M, Kurumatani N, Kurioka H, Kubo A, et al. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of systemic lupus erythematosus. Lupus. 1998;7(8):530–4.
Pullmann R Jr, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V, et al. Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene. Clin Exp Rheumatol. 1999;17(5):593–6.
Mayer NJ, Forsyth A, Kantachuvesiri S, Mullins JJ, Fleming S. Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury. Mol Pathol. 2002;55(1):29–33.
Ozturk MA, Calguneri M, Kiraz S, Ertenli I, Onat AM, Ureten K, et al. Angiotensin-converting enzyme gene polymorphism in Behcet’s disease. Clin Rheumatol. 2004;23(2):142–6.
Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab. 2000;70(4):241–51.
Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;7;471(1):45–50.
Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;1;91(5):1314–9.
Raza K, Thambyrajah J, Townend JN, Exley AR, Hortas C, Filer A, et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation. 2000;26;102(13):1470–2.
Karasneh JA, Hajeer AH, Silman A, Worthington J, Ollier WE, Gul A. Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behcet’s disease. Rheumatology. 2005;44(5):614–7.
Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P. Aqueous humor nitric oxide levels in patients with Behçet disease. Retina. 2002;22:330–5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: G. Wallace.
Rights and permissions
About this article
Cite this article
Dursun, A., Durakbasi-Dursun, H.G., Dursun, R. et al. Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease with or without ocular involvement. Inflamm. Res. 58, 401–405 (2009). https://doi.org/10.1007/s00011-009-0005-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-009-0005-y